Archive for the ‘ Defective Product ’ Category

0
22
Jun

A Child Drowns Every Five Days In Summer Months

June 22, 2011

News Channel 2 reported on a study conducted by a Nationwide Children’s Hospital doctor, who used data complied by the US Consumer Product Safety Commission to determine that a child drowns every five days in a portable “kiddie” pool during the summer months.

Statistics showed that:

  • 209 children below the age of 12-years-old died in portable pools from 2001 to 2009
  • 94% of the accidents involved children younger than 5-years-old
  • 81% of the events took place in the summer
  • Boys accounted for 56% of the accidents

Sarah Haverstick of the Safe Children Program at the Children’s Hospital at Vanderbilt Medical Center says that a child can drown in less than an inch of water.

Several suggestions were given in order to keep children safe around the pool this summer, such as:

  • adult supervision
  • fencing and gating
  • after use, portable pools should always be drained to empty and stored upside down

The article stated Vanderbilt Medical Center saw five times more drowning’s in 2010 than in 2009.

The Tennessee Personal Injury Attorneys at Hughes and Coleman care about the safety of children and have even put on an annual Children’s Safety Day since 1995. Founding attorney, J. Marshall Hughes, discussed the event in a recent news report.

Popularity: 2% [?]

Bookmark and Share
0
25
May

FDA Issues New Warnings On The Drug Terbutaline

May 25, 2011

A drug that has been used for years in mothers dealing with preterm labor now has warnings that it could cause serious heart problems or death. The U.S. Food and Drug Administation (FDA) says that the injectable version of the drug, terbutaline, should not be used for the prolonged treatment of preterm labor in a hospital or outpatient setting.

The drug is approved to prevent and treat bronchospasms (the narrowing of airways) in asthma, bronchitis, and emphysema patients; however, it has been used “off-label,” meaning an unapproved use, for acute obstetric conditions such as preterm labor and uterine hyperstimulation. Serious problems have been proven to arise in patients who used the drug for extended periods to prevent recurring preterm labor.

Studies have shown that sixteen maternal deaths have occurred since 1976 in association with the drug. Twelve cases of reported heart problems associated with terbutaline were also found.

The FDA explains that, “… The risk of serious adverse events outweighs any potential benefit to pregnant women receiving prolonged treatment with terbutaline injection (beyond 48-72 hours)… FDA is requiring the addition of a new Boxed Warning and Contraindication to the terbutaline drug labels to warn healthcare professionals about these risks.”

See founding attorney, Lee Coleman, with Hughes and Coleman Injury Lawyers discuss pharmaceutical litigation here.

Popularity: 2% [?]

Bookmark and Share
0
9
Mar

Recalled Skippy Peanut Better could be Kentucky defective product

March 10, 2011

Two products have been recalled from the manufacturer of Skippy Peanut Butter, the U.S. Food and Drug Administration reports.

Unilever United States Inc. has pulled products sold in 16 states because of a possible salmonella contamination, which could be a possible Kentucky defective product.

The two products, Skippy Reduced Fat Peanut Butter and Skippy Reduced Fat Super Chunk Peanut Butter, were recalled by the company after routine testing showed salmonella may be present.

The states affected by this product recall include: Arkansas, Connecticut, Delaware, Illinois, Iowa, Maine, Minnesota, Missouri, Nebraska, New Hampshire, New Jersey, New York, North Dakota, Pennsylvania, Virginia, and Wisconsin.

Read more.

Do you think there’s a chance the peanut butter could become a Kentucky or Tennessee defective product even though they have not yet been added to the list?

Popularity: 1% [?]

Bookmark and Share
0
12
Oct

FDA recalls 14 defective products: children’s cough and cold medicine

October 12, 2007

Drugstores across Kentucky are pulling 14 defective products from their shelves because of a Food and Drug Adminstration recall covering several over-the-counter cough and cold medicines for infants, according to Courier-Journal.

The nationwide recall came one week before the FDA’s plans for a hearing on nonprescription cough and cold medications for children, slated for Oct. 18-19. The hearing is intended to discover whether the medicines are ineffective and dangerous in light of increasing evidence of serious drug injuries and complications, which may be fatal in some cases.

McNeil Consumer Healthcare, Novartis Consumer Health Inc., and Wyeth Inc., are the pharmaceutical giants responsible for making these drugs that are involved in the recall and make up at least 95 percent of the market, according to the FDA.

Read More:
http://www.courier-journal.com/apps/pbcs.dll/article?AID=/20071012/NEWS01/71012001/1008

Popularity: 65% [?]

Bookmark and Share